ORGANIZATIONAL STRUCTURE
9 Administrative Offices: Office of General Affairs, Office of Communist Party Committee, Department of Discipline Inspection and Supervision, Department of Personnel, Department of Sciences, Department of Education, Department of Technology Development, Department of Financial Affairs and Service Centre for Scientific and Technological Study.
17 Research Centers of:
(1) Property Theory: Herbal properties and the Association with Efficacy, Principles and Applications of TCM Compatibility, Mechanisms of TCMs against Refractory Diseases, TCM-based New Drug Discovery and Development, Data Cross-platform and Intelligent Application of Chinese Materia Medica;
(2) Herbalism: Literature and Herbal Textual Study, Historical Science of Traditional Chinese Medicine, Traditional Chinese Medicine Theory, Historical Herbal Species Study and Construction of Herbal Literature Database and Knowledge Base;
(3) Pharmacognosy: Evaluation and Selection of Excellent Germplasm, Biological Formation Mechanism of secondary metabolites in Medicinal Plant, Introduction and Cultivation, Natural nursing, Identification and GAP of Chinese Medicinal Materials，Quality Control and Processing Mechanism of Mineral Medicines;
(4) Chemistry: Chemical Constituents relating to Pharmacological Effects, Key Technology and Methods of Quality Control and Integrated Utilization of TCM Materials;
(5) Analytical Chemistry: New Technology of Analysis, Comprehensive Utilization of Resources, Quality Standard of TCM Materials, Key Technologies of Storage and Packaging, Quality Promotion of Chinese Patent Medicine and Biological Characterization of Efficacy;
(6) Pharmaceutical Forms: New Pharmaceutical Forms and Techniques, New Drug Delivery Systems, New Adjuvant Material Application and Traditional Pharmaceutical Forms of Chinese Materia Medica;
(7) Processing: Processing Theories, Mechanism and Techniques and Quality Evaluation of Processed Pieces of Chinese Materia Medica;
(8) Pharmacology: Anti-cardiovascular and cerebrovascular diseases and Anti-viral Diseases;
(9) Pharmacokinetics: Pharmacokinetics of Multi-ingredients, In-vivo Exposure Regulation of Active Ingredients, Material Analysis of In-vivo Micro-ingredients of Chinese Materia Medica;
(10)Biomechanopharmacology: Pharmacodynamics in Biomechanopharmacology and Cellular Biomechanopharmacology;
(11) Safety Evaluation(GLP) : Toxicology Mechanism of Chinese Materia Medica, Safety Studies of Combination of Chinese Materia Medica and Synthetic Medicines, Toxic Chinese Materia Medica , Safety Evaluation and Commonly Used Techniques, Immunotoxicity and Toxicokinetic of Chinese Materia Medica;
(12) Safety Research of Injectable Chinese Medicine: Safety Evaluation, Quality Control, Pharmaceutical Techniques and Effectiveness of Injectable Chinese Medicines, as well as Material Bases of Their Adverse Reactions;
(13) R & D: Development Study of New Drug and Functional Food of Chinese Materia Medica, as well as their Further Development;
(14) Biotechnology: Bio-information, Systems Biology, Bioengineering, Molecular Identification of Chinese Medicinal Materials and their Genomics;
(15) Data: Genomics, Transcriptomics, Metagenomics and Data Base of Chinese Materia Medica;
(16) Holistic Integrated Study: Integration Study of Chemical Evaluation for Chinese Materia Medica based on Heredity and Chemistry；Efficacy Study of Chinese Materia Medica based on Multi-omics Integration；Cultivation Study for Large Varieties of Chinese Materia Medica based on Integration Pharmacological Tactics；Integration Study of Multi-Source Data for Traditional Chinese Medicine;
(17) Medicinal Products for Nebulization： R & D of the nebulization preparation of Chinese Materia Medica or the chemical drug ;Efficacy and safety evaluation of the nebulization preparation in pharmacology and toxicology, especially safety evaluation towards of lung and respiratory system; Study on formulation design and manufacturing process, as well as quality control research of the preparation for nebulization. The center can provides technical services as follows: R & D and registrationof the nebulization preparation as a new drug; R & D and registration of the nebulization preparation originated from the officially- marketed Chinese Materia Medica preparation, especially a Chinese Materia Medica injection； Basic study of pharmacological and toxicological effects on respiratory system (airway and lung).
2 Research Centers Attached to the institute:
(1) Resources Center for Chinese Materia Medica, CACMS : Functional gene of the Chinese Materia Medica (CMM) secondary metabolites biosynthesis, Molecular identification of CMM, Regionalization and remote sensing monitoring for CMM resources, Ecological planting and soil micro-ecological repair management for CMM resources;
(2) Qinghaosu (artemisinin) : Resource Development of Artemisia Annua(Qinghao), Pharmacological Activity Extension, Structure Modification, New Compound Preparations of Artemisinin and its Derivatives.
There are State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs and National Engineering Laboratory of Quality Control Technology of Chinese Materia Medica affiliated to the institute.
(1) State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs: Quality and formation mechanism of Dao-di Herbs, Ecological cultivation and quality ensurance of Chinese materia medica (CMM) , Endangered mechanism and conservation of CMM resources, Analysis and biosynthesis of effective constituents in CMM;
(2) National Engineering Laboratory of Quality Control Technology of Chinese Materia Medica : Quality Control Techniques, Chemical Reference Substance and Standard Comprehensive Evaluation of Chinese Materia Medica, as well as Detoxifying Technique for Elimination of Contained Toxic Materials.
4 journals are attached to the institute:
(1) China Journal of Chinese Materia Medica
(2) Chinese Journal of Experimental Traditional Medical Formulae
(3) Journal of Basic Traditional Chinese Medicine
(4) Journal of Science of Traditional Chinese Medicine
终审：小管
用户登录